-
Product Insights
NewDecompensated Cirrhosis Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2024 Update
GlobalData's clinical trial report, “Decompensated Cirrhosis - Global Clinical Trials Review, 2024" provides an overview of Decompensated Cirrhosis Clinical trials scenario. This report provides top line data relating to the clinical trials on Decompensated Cirrhosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Sector Analysis
Mergers and Acquisitions (M&A) in the Contract Manufacturing Industry – Implications and Outlook – 2023 Edition
M and A In Pharmaceutical Contract Manufacturing Industry Report Overview During 2018–22, contract manufacturing organization (CMO) merger and acquisition (M&A) deal activity increased, and the targeted manufacturers have adopted specialized capabilities such as controlled substance and containment manufacture. Despite considerable macroeconomic challenges for pharma manufacturers, 2021–22 witnessed strong M&A activity and CMO valuations, although there was a slight decline in CMO M&A activity in 2022 due to rising inflation and interest rates. The Mergers and Acquisitions (M&A) in the Contract...
-
Company Profile
Norgine BV – Company Profile
Norgine BV (Norgine), a subsidiary of Norgine Europe B.V develops, manufactures, and commercializes specialty pharmaceuticals and medical devices. The company's product portfolio spans branded drugs and devices in the areas of gastroenterology, hepatology, and cancer and supportive care. It also advances pipeline candidates for the treatment of various gastroenterological and hepatological diseases and disorders. Norgine serves healthcare systems and patients in Europe, New Zealand, and Australia. Its prominent partners include Takeda, Bausch Health, Abeona Therapeutics, Alfasigma, Amicus, China Medical System...
Add to Basket -
Sector Analysis
Chronic Kidney Disease Anemia – Global Drug Forecast and Market Analysis to 2029
Anemia is a common complication of chronic kidney disease (CKD) that is most frequently attributed to insufficient synthesis of erythropoietin (EPO) due to kidney damage. CKD anemia is highly prevalent among CKD patients and its prevalence increases as CKD progresses, affecting more than half of patients in stage V. Over the last 20 years, the CKD anemia market has grown exponentially. Treatment of CKD anemia was significantly improved following the introduction of recombinant human EPO (rHuEPO), and ESAs have dominated...
-
Product Insights
Hepatic Encephalopathy Disease – Global Clinical Trials Review, H2, 2020
GlobalData's clinical trial report, “Hepatic Encephalopathy Disease - Global Clinical Trials Review, H2, 2020" provides an overview of Hepatic Encephalopathy Clinical trials scenario. This report provides top line data relating to the clinical trials on Hepatic Encephalopathy. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also...
-
Product Insights
Liver Cirrhosis Disease – Global Clinical Trials Review, H2, 2020
GlobalData's clinical trial report, “Liver Cirrhosis Global Clinical Trials Review, H2, 2020" provides an overview of Liver Cirrhosis Clinical trials scenario. This report provides top line data relating to the clinical trials on Liver Cirrhosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Hepatic Encephalopathy Disease – Global Clinical Trials Review, H1, 2020
GlobalData's clinical trial report, “Hepatic Encephalopathy Global Clinical Trials Review, H1, 2020" provides an overview of Hepatic Encephalopathy Clinical trials scenario. This report provides top line data relating to the clinical trials on Hepatic Encephalopathy. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Liver Cirrhosis Disease – Global Clinical Trials Review, H1 2020
GlobalData's clinical trial report, “Liver Cirrhosis Global Clinical Trials Review, H1, 2020" provides an overview of Liver Cirrhosis Clinical trials scenario. This report provides top line data relating to the clinical trials on Liver Cirrhosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Postoperative Ileus Global Clinical Trials Review, H1, 2018
GlobalData's clinical trial report, “Postoperative Ileus Global Clinical Trials Review, H1, 2018" provides an overview of Postoperative Ileus clinical trials scenario. This report provides top line data relating to the clinical trials on Postoperative Ileus. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Liver Cirrhosis Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “Liver Cirrhosis Global Clinical Trials Review, H2, 2017" provides an overview of Liver Cirrhosis clinical trials scenario. This report provides top line data relating to the clinical trials on Liver Cirrhosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...